Amlodipine Besylate
Product Images NDC 57664-055

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 57664-055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Caraco Pharmaceutical Laboratories, Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel 10 mg (10mg)

Label for Amlodipine Besylate Tablets, USP 10 mg, containing 1000 tablets. The label includes pharmacist information for dispensing, storage conditions, dosage note, and safety warnings. Manufactured by Epic Pharma, LLC and labeled for Caraco Pharmaceutical Laboratories, Ltd.*

FDA Label Image

Principal Display Panel 2.5 mg (2.5mg)

Label for Amlodipine Besylate Tablets, USP 2.5 mg by Caraco Pharmaceutical Laboratories, Ltd. The label includes the NDC 57664-055-18 and states the package contains 1000 tablets. It indicates the tablets are prescription only and provides storage instructions, manufacturer information (Epic Pharma, LLC and Caraco Pharmaceutical Laboratories), and packaging details such as dispenser instructions with child-resistant closure.*

FDA Label Image

Principal Display Panel 5 mg (5mg)

Label for Amlodipine Besylate Tablets USP 5 mg, containing 1000 tablets. The label includes storage instructions, pharmacist dispensing information, and states the tablets contain Amlodipine besylate USP equivalent to 5 mg amlodipine base. Manufactured by Epic Pharma, LLC and labeled for Caraco Pharmaceutical Laboratories, Ltd. The label features a barcode and the NDC number 57664-056-18.*

FDA Label Image

Amlodipine-fig1.jpg (Amlodipine Fig1)

A line graph comparing event rates over time in months between Amlodipine and placebo groups. The horizontal axis represents time up to 24 months, and the vertical axis shows the event rate. The graph includes a statistical inset with a p-value of 0.003, hazard ratio of 0.691, and 95% confidence interval from 0.54 to 0.88, indicating comparative data analysis between the two groups.*

FDA Label Image

Amlodipine-fig2.jpg (Amlodipine Fig2)

A forest plot chart showing hazard ratios with 95% confidence intervals comparing Amlodipine versus placebo across various patient subgroups, including age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The chart indicates favorability towards Amlodipine or placebo along a horizontal axis with hazard ratio values ranging from 0.0 to 2.0.*

FDA Label Image

Chemical Structure For Amlodipine. (Amlodipine Structure)

Chemical structure diagram of amlodipine besylate, showing the molecular composition and bonding arrangement of the active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.